Dysfunctional Uterine Bleeding Clinical Trial
Official title:
The Use of Levonorgestrel-Releasing Device (Metraplant-E) in the Treatment of Dysfunctional Uterine Bleeding
Research hypothesis: Release of levonorgestrel from Metraplant-E levonorgestrel releasing
intrauterine contraceptive device is inadequate to be used as a medical line of treatment of
dysfunctional uterine bleeding.
The investigators aim to evaluate the therapeutic effect of the intrauterine system
(Metraplant-E) in the treatment of dysfunctional uterine bleeding.
Primary outcome : The investigators aim to evaluate the short term release of levonorgestrel
from the Metraplant-E levonorgestrel releasing intrauterine contraceptive devices (IUCDs).
This is in a trial to determine to what extent the intrauterine release of levonorgestrel
would reduce MBL in women with menorrhagia and if the treatment would increase the body iron
stores and the degree of patient satisfaction and acceptability of treatment for the
patients with dysfunctional uterine bleeding. This will be conducted through a questionnaire
offered to the women participating in this study which is designed on Likert scale.
Secondary outcome:
1) Endometrial biopsy prior to and 6 months after the insertion of the intrauterine system
(Metraplant-E).
3) Haemoglobin level measurement in gm/dl and serum ferritin level on same occasions as when
endometrial biopsy is done.
4) The amount of monthly menstrual blood loss after the insertion the Metraplant-E
levonorgestrel releasing intrauterine contraceptive devices using the following scores:
bleeding index,total bleeding score and Pictorial blood loss assessment chart (PBAC).
Inclusion criteria:
1. Women seeking contraception.
2. Women with history of menorrhagia.
3. Pre and perimenopausal women who are married or previously married.
4. Failure of other medical treatment to control menorrhagia such as hemostatics.
5. Women who did not tolerate copper IUD (intrauterine device) due to increased amount of
menstrual blood loss which could lead to anemia.
;
Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04528108 -
Chinese Medicine Periodic Therapy for Dysfunctional Uterine Bleeding During Adolescence With Yin Deficiency and Blood Heat Syndrome
|
Phase 2 | |
| Completed |
NCT04428684 -
COMPARISON OF A NEW FORMULATION OF GOSERELIN (Pepti 3.6 mg) to Zoladex® 3.6 mg
|
Phase 1 | |
| Recruiting |
NCT00549159 -
CavatermTM vs TCRE in Women With DUB
|
Phase 4 | |
| Not yet recruiting |
NCT04579965 -
Misotac vs Combined Oral Contraceptive Pill in the Treatment of Symptomatic Isthmocele
|
N/A | |
| Terminated |
NCT01581905 -
Study of Conventional Laparoscopic Hysterectomy Versus Robot-Assisted Laparoscopic Hysterectomy at a Teaching Institution
|
N/A | |
| Recruiting |
NCT04396483 -
Dysfunctional Uterine Bleeding After Tubal Sterilization
|
N/A | |
| Completed |
NCT01628432 -
Effect of Salpingectomy During Conservative Hysterectomy
|
N/A | |
| Terminated |
NCT01776203 -
Study of a Progestin to Prevent Bleeding Associated With Initiation of Medical Menopause With GnRH Agonist
|
Phase 4 | |
| Completed |
NCT01148420 -
DMPA & High Dose Oral Progestin (MPA) Tablets in Outpatient Treatment of Acute Excessive Vaginal Bleeding
|
Phase 4 | |
| Completed |
NCT01173965 -
Endometrial Ablation With Non-hysteroscopic Methods
|
Phase 4 | |
| Active, not recruiting |
NCT02103764 -
Efficacy of Cyclic DSG Compared With Cyclic MPA for the Treatment of Anovulatory DUB
|
Phase 3 | |
| Not yet recruiting |
NCT04290013 -
Effects of Tranexemic Acid Versus Norethisterone Acetate on Endometrial Vasculature .
|
Phase 3 |